# Sarepta Therapeutics, Inc. (SRPT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Sarepta Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SRPT/mda/fy2025/): filed 2026-03-02; accession 0001193125-26-084144 (https://www.sec.gov/Archives/edgar/data/873303/000119312526084144/srpt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SRPT/mda/fy2024/): filed 2025-02-28; accession 0000950170-25-029973 (https://www.sec.gov/Archives/edgar/data/873303/000095017025029973/srpt-20241231.htm)
- [FY 2023 MD&A](/company/SRPT/mda/fy2023/): filed 2024-02-28; accession 0000950170-24-022036 (https://www.sec.gov/Archives/edgar/data/873303/000095017024022036/srpt-20231231.htm)
- [FY 2022 MD&A](/company/SRPT/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005062 (https://www.sec.gov/Archives/edgar/data/873303/000095017023005062/srpt-20221231.htm)
- [FY 2021 MD&A](/company/SRPT/mda/fy2021/): filed 2022-03-01; accession 0000950170-22-002517 (https://www.sec.gov/Archives/edgar/data/873303/000095017022002517/srpt-20211231.htm)

Back to /company/SRPT/